Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Stanford University
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Thomas Jefferson University
Dana-Farber Cancer Institute
University of Illinois at Chicago
Celyad Oncology SA